BioXcel Therapeutics (STU:BX2) Days Inventory : 2,543.75 (As of Mar. 2024)

View and export this data going back to 2019. Start your Free Trial

What is BioXcel Therapeutics Days Inventory?

Days Inventory is also known as Days Sales of Inventory (DSI). BioXcel Therapeutics's Average Total Inventories for the three months ended in Mar. 2024 was €2.04 Mil. BioXcel Therapeutics's Cost of Goods Sold for the three months ended in Mar. 2024 was €0.07 Mil. Hence, BioXcel Therapeutics's Days Inventory for the three months ended in Mar. 2024 was 2,543.75.

The historical rank and industry rank for BioXcel Therapeutics's Days Inventory or its related term are showing as below:

STU:BX2' s Days Inventory Range Over the Past 10 Years
Min: 565.86 Med: 18401.07 Max: 36226.25
Current: 565.86

During the past 8 years, BioXcel Therapeutics's highest Days Inventory was 36226.25. The lowest was 565.86. And the median was 18401.07.

STU:BX2's Days Inventory is ranked worse than
82.7% of 653 companies
in the Biotechnology industry
Industry Median: 192.72 vs STU:BX2: 565.86

BioXcel Therapeutics's Days Inventory declined from Mar. 2023 (21,084.45) to Mar. 2024 (2,543.75).

Inventory Turnover measures how fast the company turns over its inventory within a year. BioXcel Therapeutics's Inventory Turnover for the three months ended in Mar. 2024 was 0.04.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. BioXcel Therapeutics's Inventory-to-Revenue for the three months ended in Mar. 2024 was 3.80.

BioXcel Therapeutics Days Inventory Historical Data

The historical data trend for BioXcel Therapeutics's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioXcel Therapeutics Days Inventory Chart

BioXcel Therapeutics Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Inventory

Get a 7-Day Free Trial

36,000.53

584.63

BioXcel Therapeutics Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Days Inventory	Get a 7-Day Free Trial															21,084.45	6,843.75	348.65	258.91	2,543.75

Competitive Comparison of BioXcel Therapeutics's Days Inventory

For the Biotechnology subindustry, BioXcel Therapeutics's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BioXcel Therapeutics's Days Inventory Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BioXcel Therapeutics's Days Inventory distribution charts can be found below:

* The bar in red indicates where BioXcel Therapeutics's Days Inventory falls into.

BioXcel Therapeutics Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

BioXcel Therapeutics's Days Inventory for the fiscal year that ended in Dec. 2023 is calculated as

	Days Inventory (A: Dec. 2023 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (A: Dec. 2022 )	+	Total Inventories (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (1.874	+	1.826)	/	2 )	/	1.155	*	365
=	1.85					/	1.155	*	365
=	584.63

BioXcel Therapeutics's Days Inventory for the quarter that ended in Mar. 2024 is calculated as:

	Days Inventory (Q: Mar. 2024 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (Q: Dec. 2023 )	+	Total Inventories (Q: Mar. 2024 ))	/	count )	/	Cost of Goods Sold (Q: Mar. 2024 )	*	Days in Period
=	( (1.826	+	2.244)	/	2 )	/	0.073	*	365 / 4
=	2.035					/	0.073	*	365 / 4
=	2,543.75

BioXcel Therapeutics (STU:BX2) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

BioXcel Therapeutics's Inventory Turnover for the three months ended in Mar. 2024 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	0.073	/	2.035
	=	0.04

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

BioXcel Therapeutics's Inventory to Revenue for the three months ended in Mar. 2024 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	2.035	/	0.535
	=	3.80

Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.

BioXcel Therapeutics Days Inventory Related Terms

Thank you for viewing the detailed overview of BioXcel Therapeutics's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

BioXcel Therapeutics (STU:BX2) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioXcel Therapeutics Inc (STU:BX2) » Definitions » Days Inventory

Comparable Companies

Traded in Other Exchanges

BTAI:USA

Address

555 Long Wharf Drive, 12th Floor, New Haven, CT, USA, 06511

Website

https://www.bioxceltherapeutics.com

BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology. The pipeline products of the company are BXCL501 and BXCL701. The company's commercial product, IGALMI (developed as BXCL501) is a proprietary, sublingual film formulation of dexmedetomidine approved by the FDA for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults.

BioXcel Therapeutics (STU:BX2) Headlines

No Headlines